Monitoring of percutaneous mitral valvuloplasty
CA 2553498 C · Owner: Biosense Webster, Inc. · Inventors: Schwartz, Yitzhack
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
During a minimally invasive deployment of a mitral valvuloplasty device into the coronary sinus near realtime tracking of the device is monitored to determine whether the device is compressing the left circumflex coronary artery or is likely to do so. In one embodiment of the invention one or more position sensors are included in the catheter that is used to deploy the constricting implant and or in the implant itself. The position of the device is determined during deployment and compared to the location of the left circumflex coronary artery which may be determined by mapping relative to a pre-acquired image or by simultaneous intracardiac ultrasound imaging.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 26, 2006 and granted November 12, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 26, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.